For the quarter ending 2026-03-31, ALLR has $34,923K in assets. $28,003K in debts. $19,812K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 19,812 | 14,687 | 16,895 | 17,801 |
| Receivables from atm sales | - | 0 | 0 | 0 |
| Restricted cash | 10,000 | - | - | - |
| Other current assets | 108 | 265 | 113 | 116 |
| Prepaid expenses | 3,501 | 2,110 | 1,796 | 1,357 |
| Tax credit receivable | 1,082 | 866 | 1,662 | 1,609 |
| Total current assets | 34,503 | 17,928 | 20,466 | 20,883 |
| Property, plant and equipment, net | 420 | 330 | 330 | 322 |
| Total assets | 34,923 | 18,258 | 20,796 | 21,205 |
| Accounts payable | 4,235 | 4,282 | 4,602 | 4,605 |
| Accrued expenses and other current liabilities | 2,191 | 2,667 | 2,712 | 2,977 |
| Warrant derivative liability | - | 0 | 0 | 0 |
| Income taxes payable | 81 | 81 | 81 | 81 |
| Promissory note - short term, net of discounts | 20,080 | - | - | - |
| Convertible promissory notes and accrued interest | 1,416 | 1,400 | 1,390 | 1,375 |
| Total current liabilities | 28,003 | 8,430 | 8,785 | 9,038 |
| Total liabilities | 28,003 | 8,430 | 8,785 | 9,038 |
| Common stock, 0.0001 par value (250,000,000 shares authorized) 19,032,619 and 19,030,619 shares issued and 15,818,980 and 16,080,980 outstanding at march 31, 2026, and december 31, 2025, respectively | 3 | 3 | 3 | 2 |
| Additional paid-in capital | 144,395 | 144,233 | 143,841 | 141,209 |
| Accumulated other comprehensive loss | -1,079 | -1,021 | -2,303 | -2,461 |
| Accumulated deficit | -132,947 | -130,197 | -126,824 | -124,018 |
| Treasury stock, at cost 3,213,639 and 2,949,639 shares at march 31, 2026, and december 31, 2025, respectively | 3,452 | 3,190 | 2,706 | 2,565 |
| Total stockholders equity | 6,920 | 9,828 | 12,011 | 12,167 |
| Total liabilities and stockholders equity | 34,923 | 18,258 | 20,796 | 21,205 |
Allarity Therapeutics, Inc. (ALLR)
Allarity Therapeutics, Inc. (ALLR)